000			01640 a2200493 4500
005			20250513033152.0
264		0	_c19951128
008			199511s 0 0 eng d
022			_a0143-3334
024	7		_a10.1093/carcin/16.10.2309 _2doi
040			_aNLM _beng _cNLM
100	1		_aKasper, P
245	0	0	_aIn vitro mutagenicity studies on cyproterone acetate using female rat hepatocytes for metabolic activation and as indicator cells. _h[electronic resource]
260			_bCarcinogenesis _cOct 1995
300			_a2309-14 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBiotransformation
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aCell Line
650	0	4	_aCells, Cultured
650	0	4	_aChromosome Aberrations
650	0	4	_aCoculture Techniques
650	0	4	_aCricetinae
650	0	4	_aCricetulus
650	0	4	_aCyproterone Acetate _xpharmacology
650	0	4	_aDNA _xbiosynthesis
650	0	4	_aDNA Damage
650	0	4	_aDNA Repair _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aHypoxanthine Phosphoribosyltransferase _xbiosynthesis
650	0	4	_aKinetics
650	0	4	_aLiver _xcytology
650	0	4	_aMicronucleus Tests
650	0	4	_aMutagenesis
650	0	4	_aMutagenicity Tests
650	0	4	_aRats
650	0	4	_aRats, Wistar
700	1		_aTegethoff, K
700	1		_aMueller, L
773	0		_tCarcinogenesis _gvol. 16 _gno. 10 _gp. 2309-14
856	4	0	_uhttps://doi.org/10.1093/carcin/16.10.2309 _zAvailable from publisher's website
999			_c7585569 _d7585569